Translation of the Modified Polycystic Ovary Syndrome Questionnaire (mPCOSQ) and the Polycystic Ovary Syndrome Quality of Life Tool (PCOSQOL) in Dutch and Flemish Women with PCOS

Geranne Jiskoot; Sara Somers; Chloë De Roo; Dominic Stoop; Joop Laven

doi:10.3390/jcm12123927

Translation of the Modified Polycystic Ovary Syndrome Questionnaire (mPCOSQ) and the Polycystic Ovary Syndrome Quality of Life Tool (PCOSQOL) in Dutch and Flemish Women with PCOS

Geranne Jiskoot^*, Sara Somers^*, Chloë De Roo, Dominic Stoop, Joop Laven

^*Corresponding author for this work

Obstetrics & Gynecology

Research output: Contribution to journal › Article › Academic › peer-review

1 Citation (Scopus)

66 Downloads (Pure)

Abstract

This study aims to determine the test–retest reliability and to confirm the domain structures of the Dutch version of the modified polycystic ovary syndrome questionnaire (mPCOSQ) and the Polycystic Ovary Syndrome Quality of Life Scale (PCOSQOL) in Dutch and Flemish women with Polycystic Ovary Syndrome (PCOS). PCOS patients were contacted with a request to complete both questionnaires (including additional demographic questions) online in their home environment on T0 and on T1. The study was approved by the Ethics Committee of Erasmus Medical Centre and of Ghent University Hospital. In this study, 245 participants were included between January and December 2021. The mPCOSQ has excellent internal consistency (α: 0.95) and a high to excellent Intraclass Correlation Coefficient (ICC) for all six domains (ICC: 0.88–0.96). The PCOSQOL demonstrates excellent internal consistency (α: 0.96) and ICC (ICC: 0.91–0.96) for all four domains. The original six-factor structure of the mPCOSQ is partly confirmed. An extra domain is added to the PCOSQOL which included coping items. Most women have no preference for one of the two questionnaires (55.9%). In conclusion, The Dutch mPCOSQ and PCOSQOL are reliable and disease-specific QoL measures for women with PCOS. Both questionnaires are recommended for clinical practice.

Original language	English
Article number	3927
Journal	Journal of Clinical Medicine
Volume	12
Issue number	12
DOIs	https://doi.org/10.3390/jcm12123927
Publication status	Published - 8 Jun 2023

Bibliographical note

Funding Information:
G.J. received an unrestricted research grant from the Waterloo Foundation and she received consultancy fees from Ferring. D.S. received unrestricted research grants from Ferring, Organon, Gedeon Richter, and Vitrolife. He also received consultancy fees from Ferring, Organon, Gedeon Richter, and Merck Serono. J.L. received unrestricted research grants from Ferring, Merck Serono, Roche Diagnostics, and Anshlabs. He also received consultancy fees from Ferring, Anshlabs, Roche Diagnostics, and Titus healthcare. The other authors declare no conflict of interest. ® ® ® ® ® ® ® ® ® ® ® ® ® ® ® ® ®

Publisher Copyright:
© 2023 by the authors.

Access to Document

10.3390/jcm12123927Licence: CC BY

Translation of the Modified Polycystic Ovary Syndrome Questionnaire (mPCOSQ) and the Polycystic Ovary Syndrome Quality of Life Tool (PCOSQOL) in Dutch and Flemish Women with PCOSFinal published version, 268 KBLicence: CC BY

Cite this

@article{0c638bca095b49dcaaeaf7485644b53d,

title = "Translation of the Modified Polycystic Ovary Syndrome Questionnaire (mPCOSQ) and the Polycystic Ovary Syndrome Quality of Life Tool (PCOSQOL) in Dutch and Flemish Women with PCOS",

abstract = "This study aims to determine the test–retest reliability and to confirm the domain structures of the Dutch version of the modified polycystic ovary syndrome questionnaire (mPCOSQ) and the Polycystic Ovary Syndrome Quality of Life Scale (PCOSQOL) in Dutch and Flemish women with Polycystic Ovary Syndrome (PCOS). PCOS patients were contacted with a request to complete both questionnaires (including additional demographic questions) online in their home environment on T0 and on T1. The study was approved by the Ethics Committee of Erasmus Medical Centre and of Ghent University Hospital. In this study, 245 participants were included between January and December 2021. The mPCOSQ has excellent internal consistency (α: 0.95) and a high to excellent Intraclass Correlation Coefficient (ICC) for all six domains (ICC: 0.88–0.96). The PCOSQOL demonstrates excellent internal consistency (α: 0.96) and ICC (ICC: 0.91–0.96) for all four domains. The original six-factor structure of the mPCOSQ is partly confirmed. An extra domain is added to the PCOSQOL which included coping items. Most women have no preference for one of the two questionnaires (55.9%). In conclusion, The Dutch mPCOSQ and PCOSQOL are reliable and disease-specific QoL measures for women with PCOS. Both questionnaires are recommended for clinical practice.",

author = "Geranne Jiskoot and Sara Somers and {De Roo}, Chlo{\"e} and Dominic Stoop and Joop Laven",

note = "Funding Information: G.J. received an unrestricted research grant from the Waterloo Foundation and she received consultancy fees from Ferring. D.S. received unrestricted research grants from Ferring, Organon, Gedeon Richter, and Vitrolife. He also received consultancy fees from Ferring, Organon, Gedeon Richter, and Merck Serono. J.L. received unrestricted research grants from Ferring, Merck Serono, Roche Diagnostics, and Anshlabs. He also received consultancy fees from Ferring, Anshlabs, Roche Diagnostics, and Titus healthcare. The other authors declare no conflict of interest. {\textregistered} {\textregistered} {\textregistered} {\textregistered} {\textregistered} {\textregistered} {\textregistered} {\textregistered} {\textregistered} {\textregistered} {\textregistered} {\textregistered} {\textregistered} {\textregistered} {\textregistered} {\textregistered} {\textregistered} Publisher Copyright: {\textcopyright} 2023 by the authors.",

year = "2023",

month = jun,

day = "8",

doi = "10.3390/jcm12123927",

language = "English",

volume = "12",

journal = "Journal of Clinical Medicine",

issn = "2077-0383",

publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",

number = "12",

}

Translation of the Modified Polycystic Ovary Syndrome Questionnaire (mPCOSQ) and the Polycystic Ovary Syndrome Quality of Life Tool (PCOSQOL) in Dutch and Flemish Women with PCOS. / Jiskoot, Geranne; Somers, Sara; De Roo, Chloë et al.
In: Journal of Clinical Medicine, Vol. 12, No. 12, 3927, 08.06.2023.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Translation of the Modified Polycystic Ovary Syndrome Questionnaire (mPCOSQ) and the Polycystic Ovary Syndrome Quality of Life Tool (PCOSQOL) in Dutch and Flemish Women with PCOS

AU - Jiskoot, Geranne

AU - Somers, Sara

AU - De Roo, Chloë

AU - Stoop, Dominic

AU - Laven, Joop

N1 - Funding Information: G.J. received an unrestricted research grant from the Waterloo Foundation and she received consultancy fees from Ferring. D.S. received unrestricted research grants from Ferring, Organon, Gedeon Richter, and Vitrolife. He also received consultancy fees from Ferring, Organon, Gedeon Richter, and Merck Serono. J.L. received unrestricted research grants from Ferring, Merck Serono, Roche Diagnostics, and Anshlabs. He also received consultancy fees from Ferring, Anshlabs, Roche Diagnostics, and Titus healthcare. The other authors declare no conflict of interest. ® ® ® ® ® ® ® ® ® ® ® ® ® ® ® ® ® Publisher Copyright: © 2023 by the authors.

PY - 2023/6/8

Y1 - 2023/6/8

N2 - This study aims to determine the test–retest reliability and to confirm the domain structures of the Dutch version of the modified polycystic ovary syndrome questionnaire (mPCOSQ) and the Polycystic Ovary Syndrome Quality of Life Scale (PCOSQOL) in Dutch and Flemish women with Polycystic Ovary Syndrome (PCOS). PCOS patients were contacted with a request to complete both questionnaires (including additional demographic questions) online in their home environment on T0 and on T1. The study was approved by the Ethics Committee of Erasmus Medical Centre and of Ghent University Hospital. In this study, 245 participants were included between January and December 2021. The mPCOSQ has excellent internal consistency (α: 0.95) and a high to excellent Intraclass Correlation Coefficient (ICC) for all six domains (ICC: 0.88–0.96). The PCOSQOL demonstrates excellent internal consistency (α: 0.96) and ICC (ICC: 0.91–0.96) for all four domains. The original six-factor structure of the mPCOSQ is partly confirmed. An extra domain is added to the PCOSQOL which included coping items. Most women have no preference for one of the two questionnaires (55.9%). In conclusion, The Dutch mPCOSQ and PCOSQOL are reliable and disease-specific QoL measures for women with PCOS. Both questionnaires are recommended for clinical practice.

AB - This study aims to determine the test–retest reliability and to confirm the domain structures of the Dutch version of the modified polycystic ovary syndrome questionnaire (mPCOSQ) and the Polycystic Ovary Syndrome Quality of Life Scale (PCOSQOL) in Dutch and Flemish women with Polycystic Ovary Syndrome (PCOS). PCOS patients were contacted with a request to complete both questionnaires (including additional demographic questions) online in their home environment on T0 and on T1. The study was approved by the Ethics Committee of Erasmus Medical Centre and of Ghent University Hospital. In this study, 245 participants were included between January and December 2021. The mPCOSQ has excellent internal consistency (α: 0.95) and a high to excellent Intraclass Correlation Coefficient (ICC) for all six domains (ICC: 0.88–0.96). The PCOSQOL demonstrates excellent internal consistency (α: 0.96) and ICC (ICC: 0.91–0.96) for all four domains. The original six-factor structure of the mPCOSQ is partly confirmed. An extra domain is added to the PCOSQOL which included coping items. Most women have no preference for one of the two questionnaires (55.9%). In conclusion, The Dutch mPCOSQ and PCOSQOL are reliable and disease-specific QoL measures for women with PCOS. Both questionnaires are recommended for clinical practice.

UR - http://www.scopus.com/inward/record.url?scp=85163955542&partnerID=8YFLogxK

U2 - 10.3390/jcm12123927

DO - 10.3390/jcm12123927

M3 - Article

C2 - 37373621

AN - SCOPUS:85163955542

SN - 2077-0383

VL - 12

JO - Journal of Clinical Medicine

JF - Journal of Clinical Medicine

IS - 12

M1 - 3927

ER -

Translation of the Modified Polycystic Ovary Syndrome Questionnaire (mPCOSQ) and the Polycystic Ovary Syndrome Quality of Life Tool (PCOSQOL) in Dutch and Flemish Women with PCOS

Abstract

Bibliographical note

Access to Document

Other files and links

Fingerprint

Cite this